- Home
- FMNB vs CTMX Comparison
FMNB vs CTMX Comparison
Compare FMNB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMNB
- CTMX
- Stock Information
- Founded
- FMNB 1887
- CTMX 2008
- Country
- FMNB United States
- CTMX United States
- Employees
- FMNB N/A
- CTMX N/A
- Industry
- FMNB Major Banks
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- FMNB Finance
- CTMX Health Care
- Exchange
- FMNB Nasdaq
- CTMX Nasdaq
- Market Cap
- FMNB 503.3M
- CTMX 444.3M
- IPO Year
- FMNB N/A
- CTMX 2015
- Fundamental
- Price
- FMNB $13.86
- CTMX $2.39
- Analyst Decision
- FMNB Hold
- CTMX Strong Buy
- Analyst Count
- FMNB 3
- CTMX 2
- Target Price
- FMNB $15.33
- CTMX $5.00
- AVG Volume (30 Days)
- FMNB 114.6K
- CTMX 2.0M
- Earning Date
- FMNB 07-23-2025
- CTMX 08-07-2025
- Dividend Yield
- FMNB 4.90%
- CTMX N/A
- EPS Growth
- FMNB N/A
- CTMX 128.27
- EPS
- FMNB 1.28
- CTMX 0.49
- Revenue
- FMNB $166,505,000.00
- CTMX $147,557,000.00
- Revenue This Year
- FMNB $19.04
- CTMX N/A
- Revenue Next Year
- FMNB $4.36
- CTMX N/A
- P/E Ratio
- FMNB $10.85
- CTMX $4.91
- Revenue Growth
- FMNB N/A
- CTMX 23.81
- 52 Week Low
- FMNB $11.58
- CTMX $0.40
- 52 Week High
- FMNB $16.32
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- FMNB 54.56
- CTMX 51.40
- Support Level
- FMNB $13.66
- CTMX $2.36
- Resistance Level
- FMNB $14.27
- CTMX $2.79
- Average True Range (ATR)
- FMNB 0.33
- CTMX 0.15
- MACD
- FMNB -0.04
- CTMX -0.02
- Stochastic Oscillator
- FMNB 36.94
- CTMX 36.72
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.